Published in Cochrane Database Syst Rev on January 25, 2005
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Inflammatory Bowel Disease. Dtsch Arztebl Int (2016) 1.56
Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol (2008) 1.52
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol (2012) 1.40
A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci (2008) 1.26
Vedolizumab for the treatment of ulcerative colitis and Crohn's disease. Immunotherapy (2012) 1.04
Medical management of Crohn's disease. BMJ (2008) 0.97
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Therap Adv Gastroenterol (2011) 0.92
Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol (2006) 0.90
Inflammatory bowel disease in children: current trends. J Gastroenterol (2010) 0.87
The role of enteral nutrition in patients with inflammatory bowel disease: current aspects. Biomed Res Int (2015) 0.85
Probiotics in inflammatory bowel diseases and associated conditions. Nutrients (2011) 0.85
Second Korean guidelines for the management of Crohn's disease. Intest Res (2017) 0.82
Conventional therapy for Crohn's disease. World J Gastroenterol (2006) 0.82
Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? World J Gastroenterol (2006) 0.82
Management of Crohn's disease - are guidelines transferred to clinical practice? United European Gastroenterol J (2015) 0.81
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal. Gastroenterol Res Pract (2015) 0.79
Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease. Indian J Pharmacol (2012) 0.76
Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's disease. Gastroenterol Hepatol (N Y) (2011) 0.75
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterol Hepatol (N Y) (2008) 0.75
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease. Clin Exp Gastroenterol (2009) 0.75
Management of inflammatory bowel diseases in Eastern Europe. Postgrad Med J (2006) 0.75
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease. J Nat Sci Biol Med (2016) 0.75
Crohn's disease: a clinical update. Therap Adv Gastroenterol (2015) 0.75
Common statistical errors in the design and analysis of subfertility trials. Hum Reprod (2003) 2.50
Was John Reid right? Smoking, class, and pleasure: a population-based cohort study in England. Public Health (2007) 1.43
Need for and receipt of hip and knee replacement--a national population survey. Rheumatology (Oxford) (2006) 1.15
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2004) 1.05
Nitrates for achalasia. Cochrane Database Syst Rev (2004) 0.89
Nitrates for achalasia. Cochrane Database Syst Rev (2002) 0.81
Assessing the temporal reproducibility of human esophageal motor-evoked potentials to transcranial magnetic stimulation. J Clin Neurophysiol (2006) 0.77